The present study demonstrates that high CD44 expression in the tumor periphery correlated with HI-type GBM, in which tumor invasiveness was evaluated by the specific features on MRI, whereas CD44 expression in the tumor core tended to be lower in HI-type tumor. This evidence concerns the gene CD44 and glioblastoma.